These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
417 related items for PubMed ID: 2920007
1. Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor Xa. Ofosu FA, Hirsh J, Esmon CT, Modi GJ, Smith LM, Anvari N, Buchanan MR, Fenton JW, Blajchman MA. Biochem J; 1989 Jan 01; 257(1):143-50. PubMed ID: 2920007 [Abstract] [Full Text] [Related]
2. The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin. Ofosu FA, Sie P, Modi GJ, Fernandez F, Buchanan MR, Blajchman MA, Boneu B, Hirsh J. Biochem J; 1987 Apr 15; 243(2):579-88. PubMed ID: 2443128 [Abstract] [Full Text] [Related]
3. Activation of factor V during intrinsic and extrinsic coagulation. Inhibition by heparin, hirudin and D-Phe-Pro-Arg-Ch2Cl. Yang XJ, Blajchman MA, Craven S, Smith LM, Anvari N, Ofosu FA. Biochem J; 1990 Dec 01; 272(2):399-406. PubMed ID: 2268268 [Abstract] [Full Text] [Related]
4. Inhibition of factor X and factor V activation by dermatan sulfate and a pentasaccharide with high affinity for antithrombin III in human plasma. Ofosu FA, Choay J, Anvari N, Smith LM, Blajchman MA. Eur J Biochem; 1990 Oct 24; 193(2):485-93. PubMed ID: 2226466 [Abstract] [Full Text] [Related]
7. Mechanisms for the anticoagulant effect of heparin and related polysaccharides. Ofosu FA. Nouv Rev Fr Hematol (1978); 1988 Oct 24; 30(3):155-60. PubMed ID: 2971155 [Abstract] [Full Text] [Related]
9. Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate. Ofosu FA, Buchanan MR, Anvari N, Smith LM, Blajchman MA. Ann N Y Acad Sci; 1989 Oct 24; 556():123-31. PubMed ID: 2525356 [Abstract] [Full Text] [Related]
10. Prothrombin protects factor Xa in the prothrombinase complex from inhibition by the heparin-antithrombin complex. Rezaie AR. Blood; 2001 Apr 15; 97(8):2308-13. PubMed ID: 11290592 [Abstract] [Full Text] [Related]
12. Heparin with low affinity to antithrombin III inhibits the activation of prothrombin in normal plasma. Ofosu FA, Modi G, Cerskus AL, Hirsh J, Blajchman MA. Thromb Res; 1982 Nov 15; 28(4):487-97. PubMed ID: 7164033 [Abstract] [Full Text] [Related]
15. The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate. Ofosu FA, Blajchman MA, Modi GJ, Smith LM, Buchanan MR, Hirsh J. Br J Haematol; 1985 Aug 15; 60(4):695-704. PubMed ID: 2411283 [Abstract] [Full Text] [Related]
18. An approach to assigning in vitro potency to unfractionated and low molecular weight heparins based on the inhibition of prothrombin activation and catalysis of thrombin inhibition. Ofosu FA, Smith LM, Anvari N, Blajchman MA. Thromb Haemost; 1988 Oct 31; 60(2):193-8. PubMed ID: 2851191 [Abstract] [Full Text] [Related]
19. Modulation of the enzymatic activity of alpha-thrombin by polyanions: consequences on intrinsic activation of factor V and factor VIII. Ofosu FA. Haemostasis; 1991 Oct 31; 21(4):240-7. PubMed ID: 1794749 [Abstract] [Full Text] [Related]